title: Response after treatment for advanced hepatitis C--a mortality abstract.
abstract: This article presents an analysis of a recently published study of the survival experience among a group of patients treated for hepatitis C with advanced hepatic fibrosis/cirrhosis, divided into groups based on whether or not sustained virological response was achieved. The purpose is to evaluate the magnitude of excess mortality relative to a comparison population. The potential errors inherent in generating mock age/sex distributions from limited published data are also highlighted.
authors.forename: Steven J
authors.initials: SJ
authors.lastname: Rigatti
mesh_terms: D000328:Adult; D017677:Age Distribution; D015415:Biomarkers; D006528:Carcinoma, Hepatocellular / Q000209:etiology; D003627:Data Interpretation, Statistical; D005260:Female; D006526:Hepatitis C / Q000150:complications / Q000276:immunology* / Q000401:mortality*; D006521:Hepatitis, Chronic / Q000150:complications / Q000276:immunology / Q000401:mortality; D006801:Humans; D008103:Liver Cirrhosis / Q000209:etiology; D008113:Liver Neoplasms / Q000209:etiology; D008297:Male; D008875:Middle Aged; D009426:Netherlands / Q000453:epidemiology; D012720:Severity of Illness Index; D017678:Sex Distribution; D019562:Viral Load
chemical_list: D015415:Biomarkers